Figure 1
The process of anaphylaxis. (a) Allergens stimulate the production IgE antibodies, which (b) fix themselves to the surfaces of mast cells. (c) On second exposure to the allergens, a reaction occurs on the mast cell surface, and (d) the cellular granules release histamine and other stimulators of smooth muscle contraction.
After the antigen-antibody combination has taken place, the cells release a number of physiologically active substances including histamine and serotonin. These substances are derived from granules within the cell. The histamine, serotonin, and other mediators induce spasms of the smooth muscle, such as in the bronchioles, small arteries, and gastrointestinal tract lining. A sudden drop in blood pressure occurs, followed by circulatory collapse and shock. Bronchospasms and edema cause constriction of the respiratory passageways, and breathing is very difficult. Facial edema occurs, and the heart rate increases due to constriction of the arteries. Swellings called “hives” develop at the site of injection and other areas of the skin. In severe cases, anaphylactic shock may result in death within several minutes to an hour. To relieve the symptoms, epinephrine is administered together with a smooth muscle relaxer, a drug such as cortisone to reduce swelling, and other drugs as appropriate.
Allergic reactions. Allergic reactions (allergy) are a milder, localized form of anaphylaxis. As noted, such things as foods, pollen grains, and animal dander can induce these localized reactions. IgE, basophils, and mast cells are involved, but much less than in anaphylaxis. There appears to be a genetic basis for allergic reactions, as evidenced by their distribution in families.
Cytotoxic reactions. Cytotoxic reactions are a form of immediate hypersensitivity, sometimes referred to as type II hypersensitivity. In these reactions, IgE and IgM are produced in response to stimulation by antigens. The antibodies unite with the antigens in the bloodstream, but they also unite with analogous antigens on the surface of the human body's cells. This union sets off the complement system, and destruction of the local tissue cells ensues.
An example of a cytotoxic reaction is thrombocytopenia. In this disease, antibody molecules are elicited by certain drug molecules. The antibodies unite with antigens on the surface of thrombocytes (platelets), and with complement activation, the thrombocytes are destroyed. The result is an impaired blood-clotting mechanism.
Another example of the cytotoxic reaction is agranulocytosis. In this immune disorder, antibodies unite with antigens on the surface of neutrophils. As these cells are destroyed with complement activation, the capacity for phagocytosis is reduced.
Cytotoxic reactions are also manifested by the transfusion reaction occurring when improper blood transfusions are performed. Another consequence is erythroblastosis fetalis, also known as hemolytic disease of the newborn, or Rh disease. In this condition, a pregnant woman produces Rh antibodies against the developing fetus, and when the Rh antibodies unite with Rh antigens on the surface of fetal red blood cells in a succeeding pregnancy, the red blood cells are destroyed (Figure 2 ).
The cytotoxic reaction in erythroblastosis fetalis.
Immune complex disease. Immune complexes are combinations of antigen and antibody that have the ability to fix complement. The antibodies involved are IgM or IgG, and the antigens exist in fluid as soluble antigens. Proteins or nucleic acids may be involved.
An example of immune complex hypersensitivity is serum sickness. In this condition, animal serum is administered to humans, and its proteins elicit antibody production. When the antibodies and antigens unite, they form immune complexes, which activate the complement system and cause local tissue damage. The patient may display edema of the hands, face, and feet, as well as swelling of the upper respiratory tissues and impairment of normal respiration. An inflammatory response results.
Formation of immune complexes is also involved with numerous diseases includingsystemic lupus erythematosus, rheumatoid arthritis, and glomerulonephritis.Immune complex hypresensitivity is often called type III hypersensitivity.
Delayed hypersensitivity. T-lymphocytes rather than antibodies function in cases ofdelayed hypersensitivity, also called type IV hypersensitivity. Normally these are the T-lymphocytes involved in cell-mediated immunity. The T-lymphocytes produce lymphokines, which stimulate an influx of macrophages to perform phagocytosis. In delayed hypersensitivity, the result is an exaggeration of the immune response, and the phagocytes bring about the destruction of the local tissue.
Delayed hypersensitivity (also called cellular hypersensitivity) is so named because the reaction requires a day or more to develop. One manifestation of the reaction isinfection allergy, as in the tuberculin skin test. A purified protein derivative (PPD) ofMycobacterium tuberculosis is applied to the skin superficially, and a skin reaction (swelling and redness) occurs 24 to 48 hours later if the person has had a previous exposure to the antigens of Mycobacterium tuberculosis, possibly during an episode of tuberculosis.
A second manifestation of delayed hypersensitivity is contact dermatitis. In many cases, the reaction is accompanied by large, blisterlike lesions in which vesicles are surrounded by a zone of erythema (redness). Usually, the vesicles itch intensely.
Antigens involved in contact dermatitis include metals such as nickel and mercury, cosmetics, disinfectants, and plant substances such as the resins of poison ivy, poison oak, and poison sumac. The individual can be tested to determine which antigen is the cause of allergy by performing a patch test. In this procedure, a patch containing a specific antigen is attached to the skin and left in place for 48 hours to determine if a reaction will take place.